Engineering longevity with the ZEUGMA hyperbaric chamber
As hyperbaric oxygen therapy moves beyond clinical medicine, HPO.TECH’s ZEUGMA hyperbaric chamber reflects growing interest in engineered recovery.…
COVID-19 ARDS survivors face lasting disability and high late mortality, researchers report
Four years after ICU admission, mortality remains strikingly high in ventilated COVID-19 ARDS patients, and many survivors continue…